Purchases and Sales Made in Q3 2021 in Nrx Pharmaceuticals Inc Wt Exp (NRXPW)
This table provides information about the institutional ownership of Nrx Pharmaceuticals Inc Wt Exp (NRXPW) during Q3 2021. The information is specifically focused on institutions that hold shares of NRX PHARMACEUTICALS INC WT EXP.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 02, 2021
Q3 2021
|
Cambridge Investment Research Advisors, Inc.
|
BUY
|
- |
17KNew |
$54.3K - $250K
|
17K
$849
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
2.37KNew |
$7.59K - $35K
|
2.37K
$119
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 12, 2021
Q3 2021
|
Yakira Capital Management, Inc.
Westport, CT |
SELL
|
- |
-11.7K- 28.63% |
$37.3K - $172K
|
29K
$1.45K
|
|
Nov 15, 2021
Q3 2021
|
Ionic Capital Management LLC
New York, NY |
SELL
|
- |
-20.1KClosed |
$64.4K - $297K
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Aqr Arbitrage LLC
Greenwich, CT |
SELL
|
- |
-45.7K- 45.74% |
$146K - $675K
|
54.3K
$2.71K
|